Navigation Links
CHF International Named Global Fund Principal Recipient in Honduras
Date:11/20/2007

SILVER SPRING, Md., Nov. 20 /PRNewswire-USNewswire/ -- CHF International has been selected as the Global Fund to Fight AIDS, Tuberculosis and Malaria's (Global Fund) new Principal Recipient (PR) for HIV/AIDS prevention, treatment and care in Honduras--the only country in Latin America awarded an HIV proposal in Round 3 programming.

As a PR, over the next six years, CHF will be directly responsible for managing Honduras' US$47 million in HIV-focused resources for the Global Fund, including program development, technical support, volunteer and community mobilization, pharmaceutical procurement and monitoring and evaluation. CHF International will directly sub-grant the Global Fund resources to the Honduran government and civil society organizations fighting the epidemic, while building their capacity to provide sustainable, high-quality services.

"After 20 continuous years of working in Honduras, we are extremely pleased to have the opportunity to help the country develop the sustainable systems and technical capacity needed for them to effectively respond to the HIV/AIDS epidemic on their own," said Randy Lyness, CHF International's Regional Director for Latin America and the Caribbean.

For five years, CHF International successfully managed the Sustainable Improvements to Family Health Program, a partnership of CHF, the U.S. Agency for International Development, the Honduras Ministry of Health and the National Water and Sewer Authority. The program provided grant funds to 43 government health program implementers to improve reproductive heath and child survival, infectious disease, health reform, and the prevention of HIV/AIDS and other sexually-transmitted infections.

Guided by CHF International's community-based approach, one of the organization's key efforts will be working at grassroots levels with community members and volunteers so that they can more effectively sustain their efforts in HIV education, prevention, treatment and
'/>"/>

SOURCE CHF International
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...dard for the prevention and treatment of heart att...icans living with diabetes, the standard dose of a...st future heart attacks. Researchers have recently...n diabetics with coronary artery disease (CAD) tha...
...en with a recent diagnosis of cancer in one breast...// This study was conducted by the Chapel Hill r...international research team found that MRI, or mag...ed cancer in the opposite breast in 30 of 969 wome...
...in Texas in the US almost died of a choking game. ... games.// Levi was found suspended on a rope he h...s neck onto the rope. He wanted to achieve a surgi...t replenished just before the point of unconscious...
...n in a gene linked to dopamine regulation, can lea...aving for alcohol.// The protein alpha synuclein...of dopamine function. SNCA mutations can lead to s...generative disorder Parkinson's disease, which is ...
Other Medicine News:Health News:Aspirin Resistance Is Higher in Diabetics 2Health News:MRI Screening of Other Breast Crucial for Patients Diagnosed With Cancer in One Breast 2Health News:Choking Game, Rage Among US Teens, Evokes Deep Concern 2Health News:Not Parkinson’s Disease Alon 2
(Date:8/20/2008)... you currently have a study,that is falling behind...itment tools and a budget for media but still have...ed is an extra set of hands to help,your sites nav...ditional,administrative assistance and consultatio...ays Ms. Ann Kottcamp,President of Argonauta Commu...
(Date:8/19/2008)...ire-FirstCall/ --,Pharmaceutical company Pharmaxis... Phase 3 clinical trial evaluating the long term s...s has concluded with no serious,adverse events att...nt., A total of 123 subjects started treatment wi... completed the full 12 months of the trial. Of the...
(Date:8/19/2008)...rticle Sciences Inc. has,expanded its Combination ...lot production capabilities with the installation ...line. The core of the pilot line,comprising a Haa...injection,molder, enables the production of high-q...n gives Particle Sciences the ability to go from b...
(Date:8/19/2008)... to identify molecular,signature of motor neuron d...ewswire/ -- ALS Therapy,Development Institute (ALS...iomarker effort using blood samples collected thro...These ongoing projects are part of the,Institute,s...ion of genes,and proteins, at the onset of, and th...
Breaking Medicine Technology:Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 3Particle Sciences Expands Its Combination Product Capabilities 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Sign Up Now for Project Management Essentials Three Days of Training in IT Project Management Fundamentals 2451 1Sign Up Now for Project Management Essentials Three Days of Training in IT Project Management Fundamentals 2451 2Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 1Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 2Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 3Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 4Kendle Appoints Ken Hintze PhD Vice President Global Clinical Safety 26 Pharmacovigilance 2445 1Kendle Appoints Ken Hintze PhD Vice President Global Clinical Safety 26 Pharmacovigilance 2445 2Kendle Appoints Ken Hintze PhD Vice President Global Clinical Safety 26 Pharmacovigilance 2445 3Kendle Appoints Ken Hintze PhD Vice President Global Clinical Safety 26 Pharmacovigilance 2445 4GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA 950 1GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA 950 2
....--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek tod...rmaceutical and,biotechnology companies to be firs...atment for cardiovascular disease. While,angiogene... Boston,Scientific, Baxter, and Genzyme, among oth...iological therapy for advanced,coronary artery dis...
...in The Lancet on TMC125, an Investigational NNRTI,...ire/ -- Data from two,ongoing Phase 3 studies (DUE...ult patients with documented non-nucleoside revers...ibitor (PI),resistance reached an undetectable vir...le level < 50 HIV-1 RNA copies/mL) with,TMC125 (et...
Other Medicine Technology:BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility
ManuTrain is an active wrist support that has optional features for increased stabilization.
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
3-Point® Polycentric Hinged Ulnar Deviation Splint uses safe, mild to moderate force to align the hand with ulnar deviation at the MP joints. Dorsal-based splint does not impede grasp or pinch. R
Medicine Products: